Literature DB >> 1363833

The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors.

P H Levine1, R Hoover.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1363833

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  9 in total

Review 1.  Inflammatory breast cancer clusters: A hypothesis.

Authors:  Paul H Levine; Salman Hashmi; Ashley A Minaei; Carmela Veneroso
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.

Authors:  Agnieszka W Kubica; Peter S Rose; Amy L Weaver; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

3.  Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.

Authors:  Jerry D Brewer; Tait D Shanafelt; Farzaneh Khezri; Ivette M Sosa Seda; Adeel S Zubair; Christian L Baum; Christopher J Arpey; James R Cerhan; Timothy G Call; Randall K Roenigk; Carin Y Smith; Amy L Weaver; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2014-12-02       Impact factor: 11.527

4.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

Review 5.  Epidemiology and Etiology of Leukemia and Lymphoma.

Authors:  Jordan A Baeker Bispo; Paulo S Pinheiro; Erin K Kobetz
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

6.  Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study.

Authors:  M Nørgaard; A H Poulsen; L Pedersen; H Gregersen; S Friis; M Ewertz; H E Johnsen; H T Sørensen
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

7.  Epidemic of non-hodgkin lymphoma in new zealand remains unexplained.

Authors:  Brian Cox; Chih-Wei Liu; Mary J Sneyd; Claire M Cameron
Journal:  J Cancer Epidemiol       Date:  2014-04-01

8.  Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.

Authors:  Bryan A Bassig; Qing Lan; Nathaniel Rothman; Yawei Zhang; Tongzhang Zheng
Journal:  J Cancer Epidemiol       Date:  2012-09-12

9.  Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.

Authors:  Catja Freiburghaus; Venera Kuci Emruli; Angelica Johansson; Christian Winther Eskelund; Kirsten Grønbæk; Roger Olsson; Fredrik Ek; Mats Jerkeman; Sara Ek
Journal:  BMC Cancer       Date:  2018-04-25       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.